Literature DB >> 16690136

Low density and high affinity of platelet [3H]paroxetine binding in women with bulimia nervosa.

Agneta Ekman1, Charlotta Sundblad-Elverfors, Mikael Landén, Tomas Eriksson, Elias Eriksson.   

Abstract

Impaired serotonin transmission has been suggested to be implicated in the pathophysiology of bulimia nervosa. As an indirect measure of brain serotonergic activity, the binding of tritiated ligands to platelet serotonin transporters has been studied in bulimia nervosa as well as in other putatively serotonin-related psychiatric disorders. In this study, the density and affinity of platelet serotonin transporters were assessed in 20 women meeting the DSM-IV criteria for bulimia nervosa and in 14 controls without previous or ongoing eating disorder using [(3)H]paroxetine as a ligand. In comparison to controls, women with bulimia nervosa had a significantly reduced number of platelet binding sites (B(max) = 721 +/- 313 vs. 1145 +/- 293 fmol/mg protein) and an increase in the affinity for the ligand demonstrated by a lower dissociaton constant (K(d) = 33 +/- 10 vs. 44 +/- 10 pM). A significant correlation between B(max) and K(d) values was found in patients but not in controls. Our results support the notion that bulimia nervosa is associated with a reduction in platelet serotonin transporter density. In addition, our study is the first to report that this reduced transporter density in women with bulimia nervosa is accompanied by an increase in the affinity of the transporter for the ligand.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16690136     DOI: 10.1016/j.psychres.2006.02.012

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  4 in total

Review 1.  Conceptualizing the role of estrogens and serotonin in the development and maintenance of bulimia nervosa.

Authors:  Tom Hildebrandt; Lauren Alfano; Michelle Tricamo; Donald W Pfaff
Journal:  Clin Psychol Rev       Date:  2010-05-31

2.  Mice overexpressing the 5-hydroxytryptamine transporter show no alterations in feeding behaviour and increased non-feeding responses to fenfluramine.

Authors:  A Pringle; K A Jennings; S Line; D M Bannerman; S Higgs; T Sharp
Journal:  Psychopharmacology (Berl)       Date:  2008-06-16       Impact factor: 4.530

3.  Human serotonin transporter expression during megakaryocytic differentiation of MEG-01 cells.

Authors:  Gino Giannaccini; Laura Betti; Lionella Palego; Lara Schmid; Laura Fabbrini; Caterina Pelosini; Claudia Gargini; Ylenia Da Valle; Mario Lanza; Alessandro Marsili; Margherita Maffei; Ferruccio Santini; Paolo Vitti; Aldo Pinchera; Antonio Lucacchini
Journal:  Neurochem Res       Date:  2009-12-30       Impact factor: 3.996

4.  Lack of efficacy of psychological and pharmacological treatments of disorders of eating behavior: neurobiological background.

Authors:  Francesca Brambilla; Federico Amianto; Riccardo Dalle Grave; Secondo Fassino
Journal:  BMC Psychiatry       Date:  2014-12-24       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.